FR2257305B1 - - Google Patents

Info

Publication number
FR2257305B1
FR2257305B1 FR7501007A FR7501007A FR2257305B1 FR 2257305 B1 FR2257305 B1 FR 2257305B1 FR 7501007 A FR7501007 A FR 7501007A FR 7501007 A FR7501007 A FR 7501007A FR 2257305 B1 FR2257305 B1 FR 2257305B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7501007A
Other languages
French (fr)
Other versions
FR2257305A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2257305A1 publication Critical patent/FR2257305A1/fr
Application granted granted Critical
Publication of FR2257305B1 publication Critical patent/FR2257305B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FR7501007A 1974-01-14 1975-01-14 Expired FR2257305B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enExample) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
FR2257305A1 FR2257305A1 (enExample) 1975-08-08
FR2257305B1 true FR2257305B1 (enExample) 1982-03-19

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7501007A Expired FR2257305B1 (enExample) 1974-01-14 1975-01-14

Country Status (27)

Country Link
JP (2) JPS58407B2 (enExample)
AT (1) AT345449B (enExample)
AU (1) AU500250B2 (enExample)
BE (1) BE824372A (enExample)
CA (1) CA1049406A (enExample)
CH (1) CH589453A5 (enExample)
CS (1) CS191254B2 (enExample)
DD (1) DD116239A5 (enExample)
DE (1) DE2500785B2 (enExample)
DK (1) DK140003B (enExample)
ES (1) ES433759A1 (enExample)
FI (1) FI54053C (enExample)
FR (1) FR2257305B1 (enExample)
GB (1) GB1498261A (enExample)
HK (1) HK56380A (enExample)
HU (1) HU173920B (enExample)
IE (1) IE40794B1 (enExample)
IL (1) IL46426A (enExample)
MY (1) MY8100204A (enExample)
NL (1) NL166622C (enExample)
NO (1) NO143128C (enExample)
PH (1) PH14458A (enExample)
PL (1) PL93689B1 (enExample)
SE (1) SE427238B (enExample)
SU (1) SU616997A3 (enExample)
YU (1) YU41289B (enExample)
ZA (1) ZA75259B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ATE494906T1 (de) * 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
JP5535910B2 (ja) * 2007-08-28 2014-07-02 バクスター・インターナショナル・インコーポレイテッド ウイルスワクチンを生産する方法
CA2930634C (en) 2013-11-15 2023-05-09 Novartis Ag Removal of influenza nuclear protein (np) from influenza virus preparations

Also Published As

Publication number Publication date
NO750031L (enExample) 1975-08-11
JPS50100224A (enExample) 1975-08-08
ATA21475A (de) 1978-01-15
DK140003C (enExample) 1979-10-29
NL7500301A (nl) 1975-07-16
YU5875A (en) 1984-04-30
CA1049406A (en) 1979-02-27
CS191254B2 (en) 1979-06-29
FI750014A7 (enExample) 1975-07-15
HU173920B (hu) 1979-09-28
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
JPS58407B2 (ja) 1983-01-06
IL46426A (en) 1978-01-31
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
NL166622B (nl) 1981-04-15
NO143128B (no) 1980-09-15
FR2257305A1 (enExample) 1975-08-08
SU616997A3 (ru) 1978-07-25
JPS6035326B2 (ja) 1985-08-14
DD116239A5 (enExample) 1975-11-12
AT345449B (de) 1978-09-11
DE2500785C3 (enExample) 1980-09-11
MY8100204A (en) 1981-12-31
CH589453A5 (enExample) 1977-07-15
HK56380A (en) 1980-10-16
IE40794L (en) 1975-07-14
PL93689B1 (enExample) 1977-06-30
NO143128C (no) 1980-12-29
DE2500785A1 (de) 1975-07-31
IE40794B1 (en) 1979-08-15
FI54053B (fi) 1978-06-30
ZA75259B (en) 1976-08-25
DK140003B (da) 1979-06-05
SE7500130L (enExample) 1975-07-15
PH14458A (en) 1981-07-29
JPS56127319A (en) 1981-10-06
NL166622C (nl) 1981-09-15
AU7730575A (en) 1976-07-15
FI54053C (fi) 1978-10-10
AU500250B2 (en) 1979-05-17
DK1475A (enExample) 1975-09-01
YU41289B (en) 1987-02-28
GB1498261A (en) 1978-01-18
ES433759A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
DK140003C (enExample)
DK109275A (enExample)
AR199134A1 (enExample)
CS169571B1 (enExample)
CS167778B1 (enExample)
DE2433000A1 (enExample)
CH590668A5 (enExample)
CH586801A5 (enExample)
CH591822A5 (enExample)
BG19628A1 (enExample)
DD116452A1 (enExample)
CH591790A5 (enExample)
BG20224A1 (enExample)
CH1434174A4 (enExample)
CH568119A5 (enExample)
BG22642A1 (enExample)
DD111130A1 (enExample)
CH572155A5 (enExample)
CH584385A5 (enExample)
CH579123A5 (enExample)
CH586543A5 (enExample)
CH580402A5 (enExample)
BG21563A1 (enExample)
CH572110A5 (enExample)
DD115703A5 (enExample)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse